B Braun Medical has unveiled the FDA approved 1g and 2g Cefepime for injection USP and Dextrose injection USP in its Duplex Drug Delivery System.
B Braun claims that the availability of 1g and 2g Cefepime in the Duplex System means faster, safer and accurate administration of Cefepime to patients as it can be stored ready-to-use in a container wherever and whenever it is needed.
Additionally, the Duplex Drug Delivery System is a two-compartment, flexible, eco-friendly IV container that stores pre-measured pharmaceuticals and diluent doses, B Braun said.
B Braun Medical Pharmaceuticals and Drug Delivery Marketing vice president Rob Albert said that the addition of 1g and 2g Cefepime for use in B Braun’s Duplex System underscores promise to provide healthcare professionals with solutions to improve the quality – and safety – of patient care delivery.